Pirouette Pharma
PrivateLast Round
Seed Round
Mar 10, 2026
Est. Valuation
$90M
Total Funding Raised
$15.8M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Pirouette Pharma operates in Healthcare & Life Sciences and is based in Portsmouth, New Hampshire. Its latest recorded funding round was a Crowdfunding round in May 2024.
Pirouette Pharma is a pharmaceutical company that develops a platform of automated, disk-shaped auto-injectors designed for affordability, portability, and ease of use.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Pirouette Pharma Comparables
Compare Pirouette Pharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Windgap Medical | 84% | |
| Portal Instruments | 78% | |
| SHL Medical | 75% |
For institutional investors. Book with your work email.
Pirouette Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Mar 10, 2026 | ||||
| Early Funding | Mar 28, 2025 | ||||
| Crowdfunding | May 7, 2024 | ||||
| Series A Extension | May 31, 2022 | ||||
| Grant | Sep 20, 2021 | ||||
Series A | Aug 1, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Pirouette Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute on Drug Abuse | Grant |
| NIH RADx | Grant |
| Gaingels | Series A, Crowdfunding |
| Magic Fund | Crowdfunding |
| Safar Partners | Series A, Seed, Crowdfunding |
| Asymmetry Ventures | Crowdfunding |
| Y Combinator | Series A, Crowdfunding, Accelerator |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 28, 2026
Monthly visitors increased 533% MoM.
- Mar 10, 2026
$1.08M raised in Seed Round.
For institutional investors. Book with your work email.
Pirouette Pharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Pirouette Pharma's valuation, stock price, and market status.
Is Pirouette Pharma a public or private company?
Pirouette Pharma is a private company.
What is the current stock price of Pirouette Pharma?
Pirouette Pharma is a private company, so its shares have no public market price. Caplight tracks Pirouette Pharma's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Pirouette Pharma worth (valuation)?
Pirouette Pharma's valuation is estimated at $90.0M based on funding round data.
Can I buy Pirouette Pharma stock?
Pirouette Pharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Pirouette Pharma's last funding round?
Pirouette Pharma's most recent funding round was Seed Round on March 10, 2026.
Who are the main investors in Pirouette Pharma?
Key investors in Pirouette Pharma include Safar Partners, Y Combinator.
Will Pirouette Pharma IPO soon?
No public IPO plans have been announced for Pirouette Pharma.
How can I track Pirouette Pharma secondary market activity?
Caplight tracks bids, offers, and trades in Pirouette Pharma's shares on secondary markets.